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Palliative care for patients with motor
neurone disease and their bereaved carers:
a qualitative study
Clare Mc Veigh1* , Colette Donaghy2,3, Briege Mc Laughlin2, Alison Dick4, Kiran Kaur1,5, John Mc Conville2 and
Max Watson3,6
Abstract
Background: Internationally, it is widely accepted that holistic care is as an integral part of the care for people with
motor neurone disease (MND), and their informal carers. However the optimal role of generalist and specialist
palliative care, and how it integrates with specialist neurology services, is not fully established. Using a qualitative
approach we sought to examine end of life care for people with MND in Northern Ireland, and the role of specialist
and generalist palliative care.
Methods: Qualitative study involving a convenience sample of 13 bereaved carers recruited using the Northern
Ireland MND Register. Data collection consisted of semi-structured interviews with the bereaved carers of patients
who had died 3–24 months previously with a diagnosis of MND. Data were analysed using thematic analysis.
Results: Findings illuminated variations in relation to the levels of holistic care provided to this cohort of patients.
Unmanaged respiratory and psychological symptoms caused perceived distress amongst patients. Participants’
experiences additionally highlighted reluctance amongst patients with MND to engage with services such as
specialist palliative care. Conversely, for those who received input from specialist palliative care services carers
portrayed these services to be of great benefit to the patient.
Conclusions: Patients with MND in Northern Ireland may have many unmet holistic care needs. Key areas that require
particular focus in terms of service development include neuromuscular respiratory physiotherapy and psychological
services for patients. Future research must explore an optimal model of holistic care delivery for patients with MND and
how this can be effectively integrated to best meet this patient cohorts palliative care needs.
Keywords: Amyotrophic lateral sclerosis, Motor neurone disease, Palliative care, End of life, Qualitative, Bereaved carers
Background
Motor Neurone Disease (MND) is a progressive, neuro-
degenerative disease characterised by degeneration of
the upper and lower motor neurones resulting in weak-
ness and wasting of muscles. This typically leads to loss
of mobility as well as difficulties with speech, swallowing
and breathing, with survival generally between 3 and 5
years [1]. Key strategic neurological guidelines from the
European Federation of Neurological Sciences (EFNS)
and the National Institute for Health and Care
Excellence (NICE) have recommended that all patients
with MND should receive coordinated clinic-based spe-
cialist multidisciplinary care and access to specialist pal-
liative care [2, 3]. The National Institute for Health and
Care Excellence have further recommended that a mem-
ber of the multi-disciplinary team should have expertise
in palliative care [2]. Observational studies conducted in
Ireland [4, 5], America [6] and the Netherlands [7] have
provided some evidence that specialist multidisciplinary
clinics positively impact upon survival and quality of life
in MND, however specialist palliative care was not a
core part of the multidisciplinary teams examined. For
patients with MND, early referral to specialist palliative
care services is recommended [3, 8]. There is some
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evidence to suggest that specialist palliative care im-
proves quality of life for patients with MND and their
carers [9]. Previous research has additionally illuminated
that patients with MND receiving specialist palliative
care in a hospice setting, were more likely to die in their
preferred place of death than those not attending hos-
pice [4]. International studies of patient preferences have
found that, given adequate support, patients prefer to
die at home [10].
Patients with MND in Northern Ireland (NI) are diag-
nosed by neurologists and attend either a general neur-
ology clinic or a regional MND specialist clinic held
within two different centres in NI. All patients, however,
are referred to the regional NI MND Care Centre. There
are currently six specialist inpatient facilities where spe-
cialist palliative care can be accessed by patients with
MND. Local initiatives have seen the development of an
End of Life strategy [11] in England in 2008, and a five
year palliative and end of life care strategy called ‘Living
Matters: Dying Matters’ in NI [12]. Despite these key
strategic drivers, aimed at improving palliative care for
patients with advanced progressive illnesses, a recent
qualitative study of end of life care in MND in the
United Kingdom, however, found that patients and their
carers continue to experience difficulties that are not al-
ways effectively managed [13]. The present study aims
to address the research question: What are the experi-
ences of end of life care for people with MND receiving
generalist and specialist palliative care in NI?
Aim
To explore the provision of generalist and specialist pal-
liative care in Northern Ireland, at the end of life, for
people with MND from the perspective of bereaved
carers.
Methods
Design
Due to the exploratory nature of this research it was im-
portant that the methodological approach taken aimed
to explore the individual interpretations the participants
associated with the phenomenon being investigated.
Therefore, a broad interpretivist methodological ap-
proach was found to be the most suitable to answer the
research question.. Data were collected using
semi-structured interviews with bereaved carers of pa-
tients with MND.
Settings and participants
The study recruited a total of 13 bereaved carers who
cared for a patient who had died 2–24 months previ-
ously with a diagnosis of MND. There is no widely ac-
cepted time after which it is felt appropriate to approach
carers about research following bereavement [14].
However it was felt that this period of time would allow
for recall of the patients’ experience whilst reducing the
trauma experienced by the carer. The study invited 20
bereaved carers from within the five healthcare trusts in
NI who met the inclusion criteria. The deceased pa-
tients’ details were identified through the Northern
Ireland MND register [15] which records patient and
carer details, clinical information and involved services
and therapists.. Bereaved carers had to be 18 years of age
or over, English speaking, well enough to participate and
having had significant involvement in the care of the pa-
tient. Eligible bereaved carers received a letter of invita-
tion, and information about the study. If there was no
response, a follow-up phone call was made after two
weeks to ask if they would be willing to participate.
Once a carer had agreed to take part in the study the
investigator (BM) contacted the participant by phone to
arrange an appropriate time for the interview. Full writ-
ten and verbal informed consent was obtained prior to
the interview. Thirteen bereaved carers agreed to partake
in the study and participated in a semi-structured inter-
view. Table 1 highlights the participant profiles. Partici-
pants’ ages ranged from 24 to 85 years, with a mean age
of 57.3 years.
Data collection
Data were collected through semi-structured face to face
interviews conducted in the carers’ homes in 2015. Each
interview was digitally recorded, transcribed verbatim
and was 60–90 min in length. Researcher BM conducted
the interviews with an interview schedule containing
questions and prompts agreed by the research group
(Additional file 1). BM was employed as a research nurse
with clinical experience of MND. She also received
training in qualitative interview techniques. Pseudonyms
have been used for the carers to maintain confidentiality.
Data analysis
Data were analysed by adopting King and Horrock’s ap-
proach to thematic analysis [16]. Preliminary analysis of
the interview transcripts involved the development of
descriptive themes to generate a list of emerging topics
from the data. The next stage of analysis consisted of
grouping together relevant descriptive themes to high-
light the meaning of the data and illuminate interpret-
ative themes. The final stage of analysis involved the
linkage of interpretative themes to form several over-
arching themes. Each transcript was initially analysed by
BM and then reviewed by other members of the team
(CMV, MW and CD). Themes and transcripts were then
discussed jointly for verification and agreement at regu-
lar meetings. The content of the transcripts was
reviewed by CMV, MW, AD and CD and discussed with
BM and constructive feedback given in an effort to
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support BM in continuing to conduct comprehensive
and sensitive interviews.
Rigor
Reflective questioning was used throughout the inter-
views to ensure the researcher appropriately captured
the experiences of the bereaved carers, in addition to
transcripts being reviewed by members of the research
team. Data triangulation also occurred as the study used
multiple key informants to provide a range of data
sources. Rigor was enhanced through the use of thick
description as detailed accounts were provided of partic-
ipants’ experiences. An audit trail was also maintained
to ensure an accurate account of all elements of the
study were recorded.
Ethics
Local sponsorship and governance approval was given
by the Belfast Trust Research Office. Full ethical ap-
proval was successfully granted in 2013 by the Office for
Research Ethics Committees Northern Ireland reference
14/NI/1034.
Results
Three main overarching themes emerged from the data;
the provision of holistic care, the biopsychosocial impact
of MND, and lack of death preparedness.
The provision of holistic care
Analysis of the bereaved carers’ interviews identified the
overarching theme: the provision of holistic care, devel-
oped from the interpretative themes outlined below and
illustrated through the carers’ quotes. Many factors con-
tribute to good holistic care in MND, namely the
availability of services both generic and specialist, timeli-
ness of access and patient acceptance and uptake of such
services. Two interpretative themes emerged;
Variable experiences linked to holistic service provision
Carers’ accounts conveyed variability in the level of
knowledge and experience generalist healthcare profes-
sionals had in relation to the care of a patient with
MND. Concern was raised about the lack of specialist
knowledge of MND.
‘That was the vibe I was getting, that MND was
something she (physiotherapist) didn’t have much
experience with’. (Carer 6).
‘It was a learning curve for a lot of the people
(healthcare professionals) who helped us. I don’t think
they had dealt with these situations before you know’.
(Carer 13).
However, carers who experienced specialist MND sup-
port expressed a feeling of support from the MND nurse
based upon her apparent knowledge of the condition:
‘I think she (MND nurse) was the only one who
understood’. (Carer 4).
‘It felt good to have someone (MND nurse) to give you
that wee bit more of a clear understanding as to what
was going on’. (Carer 6).
Out of the 13 patients, 5 had specialist palliative care
input and carers perceived this to be of great benefit to
the patient. Specialist palliative care input involved
Table 1 Participant profiles
Carer Gender Relationship to
patient
Living
together
Patient survival from
diagnosis, m
SPCa Time post bereavement (months)
1 F wife Y 6 No 8
2 M grandson N 8 No 23
3 F daughter Y 13 No 23
4 F wife Y 11 No 23
5 M husband Y 9 No 7
6 F daughter Y 7 No 12
7 F daughter N 10 No 13
8 M husband Y 41 No 15
9 M husband Y 42 Yes – SPC Nurse/ Day hospice 18
10 F wife Y 36 Yes - SPC Nurse 14
11 M husband Y 10 Yes - Hospice (Inpatient) 18
12 F wife Y 100 Yes - Hospice (Inpatient) 18
13 F wife Y 30 Yes - SPC Nurse 24
aSPC, Specialist palliative care involvement
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either nurse support in patients’ homes or hospice ser-
vices, both inpatient and outpatient.
‘She enjoyed her time in the hospice...they were very
good to her’. (Carer 11).
‘I don’t know what I would have done without them
(specialist palliative care sit in service) … it was great,
a fantastic service. It meant you could have gone and
got rest without constant interruption’. (Carer 13).
However, some carers felt appreciative of the support
provided by generalist healthcare professionals in the
community care setting such as general practitioners
and district nurses. Patients with MND at the end of life
are often too unwell to attend hospital and so primary
care input can be a valuable support.
‘I would put it all down to the GPs (General
Practitioners), the two GP’s were out nearly every day,
they were fantastic’. (Carer 7).
Uptake of services
There appeared also to be a lack of engagement by pa-
tients, with some often refusing services to aid their hol-
istic needs. In some transcripts there was an indication
that a lack of acceptance of the disease, as well as low
mood, was contributing factors to poor engagement and
lack of service uptake.
‘Everything he (doctor) said to him he said he didn’t
need it so that was just his line, “I don’t need it”…..
they must have came about five or six times about the
hospital bed and he sent it away ‘. (Carer 10).
‘He (patient) was very quiet on it...... didn’t want
anybody (healthcare professionals).. I think he gave
up.... he didn’t want to be bothered’. (Carer 4).
In many transcripts a reluctance to engage with spe-
cialist palliative care services was evident. A carer indi-
cated in one such transcript that this may have been due
to lack of familiarity at an earlier stage.
‘Daddy had totally said the hospice was a no no…
maybe if they’d (specialist palliative care team) been
involved a bit sooner he wouldn’t have been so
negative’. (Carer 6).
The biopsychosocial impact of MND
Analysis of the bereaved carers’ interviews identified the
overarching theme: the biopsychosocial impact of MND,
developed from the interpretative themes outlined below
and illustrated through the carers’ quotes. Patients with
MND experience a wide range of symptoms with overlap
between the physical and psychological effects of the dis-
ease. In addition, patients often require input from mul-
tiple healthcare professionals from different specialties
due to the complexity of the disease, necessitating the
need for good communication. Two interpretative
themes emerged.
Unmanaged psychological symptomatology
Psychological symptoms were common complaints when
carers were asked about the main symptoms in the last
three months of life. Carers seemed to easily identify
these symptoms.
‘All night you would have heard her moaning because
she didn’t want to go to sleep..... I think it was more
fear than pain’. (Carer 3).
Many carers noted an absence of psychological therapy
and input within the health service. One carer expressed
that psychological support would have been beneficial to
the patient they cared for:
‘Mum mentioned that she would have liked to have
talked about how she was feeling spiritually... she felt
counselling would have been helpful’. (Carer 5).
Unmanaged respiratory symptoms and lack of recognition
and anticipation
Respiratory symptoms accounted for the vast majority of
physical symptoms at the end of life. In addition it is
worth noting the interplay between respiratory and psy-
chological symptoms. Concerns were raised about the
recognition of respiratory impairment in patients by
medical staff. Carers’ accounts illuminated an unmet
need with regards to the respiratory symptoms experi-
enced by patients with MND:
‘He (respiratory physician) was under the impression
that (husband) didn’t need any help… I kept saying he
does need help….he doesn’t sleep and he feels a
shortness of breath… I wish there was more knowledge
about how things can escalate’. (Carer 1).
‘He got frightened sometimes with his breathing...... he
said he couldn’t breathe and they took him in, they
kept him the one night and he came back and always
his breathing’. (Carer 4).
Non-invasive ventilation (NIV) is used to alleviate the
symptoms caused by the respiratory impairment in
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MND [3]. A lack of adjustment to NIV is likely to contrib-
ute to poor symptom control. Difficulties tolerating
non-invasive ventilation were prominent, with carers
reporting the most troubling symptoms as breathing, agi-
tation and fear. There appeared to be significant overlap
in patient’s respiratory and psychological symptomatology:
‘Well the agitation and fear was solely concerned with
his breathing. I mean once that machine became
unattached he absolutely panicked’. (Carer 13).
‘We had the NIV for him but he was afraid to use it,
then in the end it became kind of too strong for him
anyway’. (Carer 10).
Cough impairment is often a forerunner to ventilatory
failure and presents as difficulty expectorating phlegm, a
very distressing symptom for patients without appropri-
ate management. Difficulties with phlegm expectoration
were frequently described, often necessitating unplanned
hospital admissions:
‘We had the whole blue light scenario all the way to
(the hospital) just for the consultant to come and
apologise to us…he said I can’t do anything here... with
us the big issue was the mucus and it can be
frightening and people need good support…. there isn’t
enough understanding of MND’. (Carer 6).
Many carers additionally expressed that the patient
they cared for struggled for breath at the end of life:
‘It (patient’s death) was horrendous to watch… it was
the gasping for breath’. (Carer 10).
Lack of death preparedness
Analysis of the bereaved carers’ interviews identified the
overarching theme: lack of death preparedness, devel-
oped from the interpretative themes outlined below and
illustrated through the carers’ quotes. MND is a progres-
sive non-curative disease and guidance suggests that,
where the opportunity arises, attempts should be
made to discuss a patient’s wishes and make advance
care plans including advance decisions to refuse
treatment [2, 3]. These can be difficult and very
sensitive discussions.
Awareness of end of life
A lack of awareness that the end of life was approaching
was frequently described by carers:
‘The thing was that we didn’t really know it was
happening (patient dying) … I think it was just a real
shock for them all (ward nurses)…I just don’t think
they realised… it was really quick’. (Carer 13).
Some carers perceived that the healthcare profes-
sionals involved in the patient’s care were aware the pa-
tient was approaching end of life, but this was not
shared with family.
‘She (Occupational Therapist) told us after (patient) had
died that she knew she wasn’t going to last… she didn’t
lie to us but she didn’t want to hurt us’. (Carer 3).
Five patients out of 13 had made an advance decision
to refuse treatment (ADRT). For those patients who had
not made an ADRT a number of issues were raised in-
cluding a lack of awareness of ADRT as well as lack of
opportunity to discuss end of life:
‘We never really knew anything about that (ADRT)’.
(Carer 2).
‘It would have been good if she had had the
opportunity (to discuss end of life)’. (Carer 5).
Place of death
Five patients with MND died at home, one in hospice
and seven in hospital. Of those who did not die at home,
some carers perceived that they did not die in their pre-
ferred place:
‘We fought with them (hospital staff ) to take him
home….that was his wishes.’ (Carer 2).
Difficulties arose for some carers when patients were
urgently admitted to hospital at the end of life. One
carer questioned the appropriateness of medical inter-
ventions at the end of life for those that died in hospital.
Another had difficulty accessing the ward to visit.
‘They (medical team) wanted him to have more oxygen
and I said no… I said I just want him to be
comfortable… could we please have the oxygen that goes
in the wee tubes and they said he needed more support
than that…he was afraid of the masks’. (Carer 1).
‘I said when can we see her? And she said well visiting
is not until 2pm, so we couldn’t get in.’ (Carer 5).
Discussion
Present findings illuminated bereaved carers’ perceptions
that patients with MND often experienced variances in
the holistic care delivered by healthcare professionals,
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with differing levels of knowledge and skills evident in
relation to the illness. Concurrent with previous research
[17–19], participants identified a lack of knowledge in
relation to the holistic care needs and management of
patients with MND amongst generalist palliative care
providers. Similar to the study conducted by Bentley et
al. [19], for those healthcare professionals that appeared
to understand MND well, great benefits were noted by
participants. However present findings additionally dis-
covered that community healthcare professionals, such
as GPs and district nurses, played a key role in managing
the patients holistic care needs. Additionally, a lack of
recognition and optimal management of psychological
and respiratory symptoms experienced by patients with
MND was evident within participant accounts. This
highlights the need for a model of palliative care for pa-
tients with MND that optimises the integration between
specialist MND, specialist palliative care and generalist
healthcare providers [20].
Conversely, findings demonstrated perceptions that
many patients with MND were reluctant to fully avail of
the services offered to them. Foley et al. (2014) exam-
ined 34 patients employing qualitative interviews in an
effort to assess the psycho-social processes that underpin
how patients with MND engaged with healthcare ser-
vices. They identified that control, reassurance, and trust
are key variables that shape how people with MND en-
gage with healthcare services [21]. If patients with MND
consider the healthcare professionals involved in their
care to have optimal knowledge of their condition then
this may increase their engagement with services provid-
ing holistic care.
It is recognised that psychological support is an integral
part of holistic MND care [3, 22]. Reported rates of
depression in MND are variable with little correlation
with physical disability [23], however higher levels of
anxiety and depression are related to poorer health related
quality of life amongst this patient cohort [24, 25]. Present
findings offered perceptions that, although patients expe-
rienced various psychological symptoms, such as fear and
anxiety, there was a lack of formal psychological support
available. It is important that patients with MND have
access to formal psychological support to optimise holistic
symptom management [26]. Furthermore, there appeared
to be an overlap in the respiratory and psychological
symptomatology experienced by patients. Shortness of
breath, fear and anxiety were often present together.
Research has demonstrated that NIV improves survival,
quality of life and cognitive function [27–29] for people
with MND. Present findings displayed perceptions that a
lack of recognition of respiratory impairment and interven-
tion appeared to have contributed to suboptimal symptom
control. The perceptions of the bereaved carers illuminated
that quite often the presentation of respiratory crisis
resulted in an emergency hospital admission for the patient
with MND. Additionally, experiences suggested that pa-
tients with MND had difficulties in relation to appropriately
utilising NIV. These findings highlight the importance of
respiratory input into MDT services as well as the need for
education on neuromuscular respiratory impairment for
those delivering palliative care to patients with MND. .
Our study highlighted a lack of death preparedness
[30] amongst bereaved carers of patients with MND.
Death preparedness can be defined as the readiness for
death [31] experienced by the patient and their carer. A
contributing factor to being prepared for death is also an
awareness of dying [32], however carers portrayed that
they were unaware the patient with MND was going to
die. This finding confers with previous research demon-
strating a lack of death preparedness amongst patients
and carers with other forms of non-malignant condi-
tions, such as non-malignant respiratory disease [33, 34,
19]. The present study also aligned with the theory of
closed awareness which refers to the patient, and poten-
tially the carer, being unaware of the patient’s poor prog-
nosis however the healthcare professionals involved in
their care are aware and have not shared this informa-
tion [35]. This demonstrates the importance of effective
information sharing between healthcare professionals,
patients with MNDs and their carers. Additionally, this
particular finding may provide further insight into why
less than half of patients in the present study had com-
pleted an ADRT.
Limitations
Findings only represented the perspectives of bereaved
carers and not the patient’s own perspective, however
caregivers can be good proxies for patients [4]. Addition-
ally, this study did not explore the perceptions of health-
care professionals involved with this patient group
which may have enhanced the findings.
Conclusion
This study illuminated the need for the integration of
neurology and palliative care when designing services for
patients with MND as a key priority. This would facili-
tate the sharing of expertise and better support health-
care professionals to engage in advance care planning
with patients with MND, and their carers. In addition a
good understanding of neuromuscular respiratory im-
pairment and its overlap with psychological symptoms
at the end of life in MND is imperative for those deliver-
ing palliative care to patients. This would enable symp-
toms to be identified in a timely manner and effectively
managed.. Finally, establishing the optimal model of in-
tegration of neurology and specialist palliative care ser-
vices could serve as a template for the management of
other progressive neurodegenerative disorders.
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